How does rasalect work? A detailed pharmacological overview
•
4 min read
Affecting more than 10 million people worldwide, Parkinson's disease is a chronic and progressive neurodegenerative disorder caused by the loss of dopamine-producing neurons. Rasalect, a brand name for rasagiline, works by specifically targeting an enzyme that breaks down dopamine, thereby increasing its availability in the brain to help control motor symptoms.
